Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):1050-1051. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0310

View: 660 Download: 20

Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):1048-1049. Published online August 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0261

View: 946 Download: 24

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 1040 Download: 129

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity

Gi-Ae Kim, Joon Ho Moon, Won Kim

Clin Mol Hepatol. 2023;29(4):831-843. Published online August 25, 2023

DOI: https://doi.org/10.3350/cmh.2023.0277

View: 1879 Download: 239 Citations: 3

Erratum

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Seok Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Clin Mol Hepatol. 2023;29(3):830-830. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0345e
Corrects: Clin Mol Hepatol 2023;29(2):496

View: 1135 Download: 19

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):828-829. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0054e
Corrects: Clin Mol Hepatol 2023;29(2):367

View: 1027 Download: 19

Correspondence

Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):823-824. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0182

View: 1323 Download: 37 Citation: 1

Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):821-822. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0183

View: 1306 Download: 63 Citation: 1

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):820-820. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135

View: 1103 Download: 26

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”

Seul Ki Han, Soon Koo Baik, Moon Young Kim

Clin Mol Hepatol. 2023;29(3):817-819. Published online May 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0155

View: 1224 Download: 38

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):513-515. Published online February 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044

View: 1577 Download: 41

Special thanks

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S4-S4. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0010

View: 1361 Download: 33

Preface

Yoon Jun Kim

Clin Mol Hepatol. 2023;29(Suppl):S2-S2. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0011

View: 1400 Download: 31

Preface

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S3-S3. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0014

View: 1370 Download: 42

Congratulatory remarks

Si Hyun Bae

Clin Mol Hepatol. 2023;29(Suppl):S1-S1. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0027

View: 1536 Download: 44

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”

Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2023;29(1):191-193. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0410

View: 2057 Download: 56

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0408

View: 2434 Download: 52 Citations: 2

Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”

Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn

Clin Mol Hepatol. 2023;29(1):185-187. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0375

View: 2044 Download: 32

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”

Won Sohn, Yong-Han Paik

Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0411

View: 2210 Download: 35

Erratum

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]

Clin Mol Hepatol. 2022;28(4):940-940. Published online September 7, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084.e1
Corrects: Clin Mol Hepatol 2022;28(2):276

View: 2049 Download: 47 Citations: 2

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Do Young Kim

Clin Mol Hepatol. 2022;28(4):939-939. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2021.0277.e1
Corrects: Clin Mol Hepatol 2021;27(4):620

View: 2135 Download: 34

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 5109 Download: 72 Citations: 6

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 6661 Download: 190 Citations: 33

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 5344 Download: 160 Citations: 15

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights

Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina

Clin Mol Hepatol. 2020;26(4):728-735. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0202

View: 5381 Download: 177 Citations: 25

Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases

Yun Seok Kim, Sang Geon Kim

Clin Mol Hepatol. 2020;26(4):715-727. Published online September 22, 2020

DOI: https://doi.org/10.3350/cmh.2020.0173

View: 7867 Download: 245 Citations: 27

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul

Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0166

View: 3915 Download: 84 Citations: 7

Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell

Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong

Clin Mol Hepatol. 2020;26(4):697-704. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0152

View: 5108 Download: 135 Citations: 6

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0145

View: 5304 Download: 204 Citations: 14

Roles of the complement system in alcohol-induced liver disease

Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He

Clin Mol Hepatol. 2020;26(4):677-685. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0094

View: 5750 Download: 134 Citations: 9

Viewed By 4788	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4753	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3767	MAFLD: How is it different from NAFLD?
Viewed By 2613	Management of refractory ascites
Viewed By 2455	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 131	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 78	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 60	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 55	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 54	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Others